Time For Independent FDA? COVID-19 Political Pressure Reignites Debate
Executive Summary
The political spotlight on the Food & Drug Administration during the COVID-19 pandemic has renewed the long-standing debate as to whether FDA should be made an independent, Cabinet-level federal agency and freed from direct HHS oversight.
You may also be interested in...
Califf On Getting Someone Younger Than 70 To Take FDA Commissioner Job
Robert Califf says there is a reason there is such a high turnover in the top post. He notes that the continuity and dedication of center directors is one of the reasons he returned.
Politics Is US FDA Commissioners’ Biggest Challenge, Ex-Trump Agency Head Hahn Says
In a Pink Sheet interview, Stephen Hahn also discusses the unique risk-benefit calculations that may come into play for the ‘preemptive’ therapeutics he hopes to spearhead in his new position at Flagship Pioneering and his tendency to follow in the career path of another former commissioner, Scott Gottlieb.
Politics Is US FDA Commissioners’ Biggest Challenge, Ex-Trump Agency Head Hahn Says
In a Pink Sheet interview, Stephen Hahn also discusses the unique risk-benefit calculations that may come into play for the ‘preemptive’ therapeutics he hopes to spearhead in his new position at Flagship Pioneering and his tendency to follow in the career path of another former commissioner, Scott Gottlieb.